The Connolly Hospital Blanchardstown is a teaching hospital in Blanchardstown, Dublin, Ireland. It is managed by RCSI Hospitals.

There are 407 beds in Connolly Hospital, Blanchardstown.

During the past decade, Connolly Hospital, Blanchardstown conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 3 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Connolly Hospital, Blanchardstown" #1 sponsor was "Royal College of Surgeons, Ireland" with 3 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Connolly Hospital Blanchardstown" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Connolly Hospital, Blanchardstown" #1 collaborator was "Connolly Hospital Blanchardstown" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Health Research Board, Ireland" with 2 trials as a collaborator, "Atea Pharmaceuticals, Inc." with 1 trials as a collaborator and "Health Service Executive, Ireland" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Connolly Hospital, Blanchardstown" are "Diabetes Mellitus, Type 2" (2 trials), "Achilles Tendon Pain" (1 trials), "Asthma" (1 trials), "COVID-19" (1 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Connolly Hospital, Blanchardstown" in a lesser frequency.

Most popular intervention types in "Connolly Hospital, Blanchardstown" are "Drug" (7 trials), "Other" (3 trials), "Behavioral" (1 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "linagliptin" (2 trials), "AT-527" (1 trials), "BMS-986165" (1 trials) and "Colchicine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Connolly Hospital, Blanchardstown" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Connolly Hospital, Blanchardstown". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Connolly Hospital, Blanchardstown, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Connolly Hospital, Blanchardstown, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".